Gastroenterologist Joseph Salhab, DO, shared his top ten natural laxatives to aid with regular bowel movements. Meanwhile, ...

"Statements suggesting AI is inherently better informed than physicians, or that physicians cannot be trusted to make ...

An investigational dual GIP/GLP-1 agonist achieved modest weight loss in adults with type 2 diabetes and obesity, the phase ...

Starting a GLP-1 receptor agonist after giving birth is becoming more common, an analysis of claims data showed. The ...

Cemdisiran, an investigational small interfering RNA (siRNA) therapeutic targeting complement component 5 (C5), led to fewer ...

Three Republican states went to the Supreme Court on Wednesday to challenge abortion "shield laws" protecting providers in ...

The FDA approved the Autus Size-Adjustable Valve for surgical pulmonary valve replacement in children with congenital heart ...

Adults with type 2 diabetes achieved impressive weight loss with an investigational combination agent of eloralintide plus ...

Users of GLP-1 receptor agonists had as much as fourfold higher likelihood for nail disorders, particularly onycholysis (separation of the fingernails or toenails), compared with patients not taking ...

A woman on death row in Tennessee survived two doses of lethal injection before her execution was called off. (The Hill) ...

A phase II trial produced promising safety and efficacy data for investigational tipelukast as a treatment for hypertriglyceridemia and MASLD associated with type 2 diabetes, MediciNova announced.

Early HER2-Positive Breast Cancer," Cleveland Clinic breast oncologist Megan Kruse, MD, and host John Mangels discuss how clinicians can navigate increasingly complex treatment decisions while helping ...